Literature DB >> 28331846

Active Immunotherapy for Alzheimer's Disease: The Road Ahead.

M S Rafii1.   

Abstract

Entities:  

Year:  2015        PMID： 28331846      PMCID： PMC5358324          DOI： 10.14283/jpad.2015.59

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN： 2274-5807


× No keyword cloud information.
  12 in total

1.  Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.

Authors:  J-M Orgogozo; S Gilman; J-F Dartigues; B Laurent; M Puel; L C Kirby; P Jouanny; B Dubois; L Eisner; S Flitman; B F Michel; M Boada; A Frank; C Hock
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

2.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS.

Authors:  I KLATZO; H WISNIEWSKI; E STREICHER
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

3.  Aluminium incorporation into the brain of rat fetuses and sucklings.

Authors:  S Yumoto; H Nagai; H Matsuzaki; H Matsumura; W Tada; E Nagatsuma; K Kobayashi
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

4.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

Review 5.  Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?

Authors:  Lucija Tomljenovic
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method.

Authors:  H Murayama; R W Shin; J Higuchi; S Shibuya; T Muramoto; T Kitamoto
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Brain aluminum in aging and Alzheimer disease.

Authors:  J R McDermott; A I Smith; K Iqbal; H M Wisniewski
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

Review 8.  Neurofibrillary pathology and aluminum in Alzheimer's disease.

Authors:  R W Shin; V M Lee; J Q Trojanowski
Journal:  Histol Histopathol       Date:  1995-10       Impact factor: 2.303

9.  Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.

Authors:  Sakae Yumoto; Shigeo Kakimi; Akihiro Ohsaki; Akira Ishikawa
Journal:  J Inorg Biochem       Date:  2009-08-15       Impact factor: 4.155

10.  Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Authors:  S Gilman; M Koller; R S Black; L Jenkins; S G Griffith; N C Fox; L Eisner; L Kirby; M Boada Rovira; F Forette; J-M Orgogozo
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.